Kidney Cancer Drug May Treat Osteoarthritis

Pazopanib (Votrient, Novartis), a vascular endothelial growth factor inhibitor used to treat kidney cancer, may also have a role in treating osteoarthritis (OA). In a mouse model, pazopanib immediately relieved OA pain and inhibited cartilage degeneration.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ